GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.6198 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.8187 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, ESR1, FABP3, FABP4, FDPS, HMGCR, HSD17B2, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
10.3928 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, FDPS, HMGCR, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, TYR, XDH |
10.3928 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HMGCR, HSD17B2, KDR, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SLC1A1, SLC6A2, SLC6A3, SRC, XDH |
9.5905 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
9.5905 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2 |
9.4241 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AXL, CA9, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, ESR1, FABP3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, MMP2, MMP9, PIK3CA, PPARA, PTGS2, RORC, SLC6A3, SRC, TYR |
9.12349 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, KDR, MMP2, PIK3CA, PPARA, PTGS2, RORC, SLC6A3, SRC, TYR |
8.93287 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, DRD4, FABP3, PPARA, SLC1A1 |
8.90522 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2 |
8.73125 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2 |
8.45754 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, ALPL, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, KDR, MMP2, MMP9, PIK3CA, PPARA, PTGS2, RORC, SLC6A2, SLC6A3, SRC, TYR |
8.21474 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, FABP3, FABP4, FDPS, HMGCR, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
8.10857 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, DRD2, DRD3, DRD4, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS2 |
7.50442 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, DRD2, DRD3, DRD4, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS2 |
7.50442 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, DRD4, FABP3, PPARA, SLC1A1 |
7.40229 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, ESR1, FDPS, HMGCR, HSD17B2 |
7.37191 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2 |
7.28885 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2 |
6.99869 |
[BP] GO:0007215 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.99139 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
6.86052 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PPARA, PTGS1, PTGS2 |
6.60619 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, PTGS2, SLC6A3, SRC |
6.47915 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, ALOX15, AXL, CA2, CA7, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, FLT3, GRM1, HCAR2, HMGCR, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
6.4258 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, ALOX15, AXL, CA2, CA7, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, FLT3, GRM1, HCAR2, HMGCR, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
6.39878 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HMGCR, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
6.23523 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD2, GRM1, GRM3, GRM5, GRM8, PTGS2 |
6.1757 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AXL, CYP19A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, FABP4, GRM1, GRM5, GRM8, HMGCR, HSD17B2, IGF1R, MET, MMP1, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RORC, SLC6A2, SLC6A3, SRC, TYR |
6.13576 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, FDPS, HMGCR, SLC6A3, TYR |
6.10588 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, DRD4, FABP3, GRIA2, GRIA4, GRIK5, PPARA, SLC1A1, SLC6A2, SLC6A3 |
6.06845 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ALOX15, CDC25B, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
6.04891 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ALOX15, CDC25B, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
5.98761 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, FLT3, PTGS2, RORC, SLC6A3, SRC, TYR |
5.88204 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.78776 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, DRD3, FABP3, FDPS, FLT3, HCAR2, HMGCR, PPARA, PTGS2, RORC, SRC |
5.75712 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, AXL, CYP1B1, DRD2, DRD4, FLT3, GRM1, HMGCR, KDR, MET, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.75208 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.75208 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.75208 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.69669 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, NQO2, PTGS1, RORC |
5.65364 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.51073 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CYP1B1, CYP2D6, DRD2, DRD3, DRD4, ESR1, FABP4, GRM3, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC |
5.40397 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, HMGCR, KDR, SLC6A3, SRC |
5.35263 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.27119 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD2, DRD3, DRD4, GRIK5, PTGS2, SLC1A1, SLC6A2, SLC6A3 |
5.21806 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.21026 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CYP1B1, ESR1, FLT3, GRIK5, HCAR2, HMGCR, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, XDH |
5.19879 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, ALPL, AURKB, AXL, CA2, CA6, CA9, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HMGCR, HSD17B2, IGF1R, KDR, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A3, SRC, TYR |
5.13991 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HCAR2, HMGCR, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC1A1, SLC6A3, SRC, XDH |
5.13991 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, AXL, CA12, CA2, CA7, DRD2, DRD3, DRD4, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, MET, PIK3CA, PIK3CB, SRC |
5.13902 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, DRD3, DRD4, ESR1, ESR2, FABP3, FABP4, FDPS, FLT3, HMGCR, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SRC, TYR, XDH |
5.13649 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, AURKB, AXL, CYP1B1, DRD2, DRD3, DRD4, ESR1, FLT3, GRM1, HMGCR, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.11732 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CYP1B1, ESR1, FLT3, GRIK5, HCAR2, HMGCR, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, XDH |
5.08624 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CA9, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, FABP3, HMGCR, KDR, PTGS2, SLC6A2, SLC6A3, SRC |
5.08624 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ALOX15, CDC25B, DRD2, DRD4, FABP3, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.08624 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ALOX15, CDC25B, DRD2, DRD4, FABP3, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.08624 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, FABP3, FLT3, GRIK5, GRM1, GRM5, HCAR2, HMGCR, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, XDH |
5.00559 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.99497 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, DRD3, DRD4, ESR1, ESR2, FABP3, FABP4, FDPS, FLT3, HMGCR, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SRC, TYR, XDH |
4.76968 |
[BP] GO:0007188 |
None
|
ADORA1, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
4.74154 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, DRD2, DRD3, HCAR2, HMGCR, KDR, PIK3CB, PTGS2, SRC |
4.67194 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PPARA, PTGS1, PTGS2 |
4.63909 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, AXL, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, MMP9, PIK3CA, PTGS2, RORC, SRC |
4.59593 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, CA12, CA2, CA7, DRD2, DRD3, DRD4, ESR1, FABP3, FABP4, GRIK5, GRM1, GRM5, MET, PIK3CA, PIK3CB |
4.52855 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
4.52126 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CYP1B1, ESR1, FLT3, GRIK5, HCAR2, HMGCR, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, XDH |
4.52126 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.52126 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, AXL, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, PIK3CA, PTGS2, RORC, SRC |
4.51625 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, AXL, CYP1B1, DRD2, DRD3, DRD4, FLT3, GRM1, HMGCR, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.49468 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, CA2, CA9, CYP1A1, CYP1A2, ESR1, FABP3, FLT3, HSD17B2, PTGS2, RORC, SRC, TYR |
4.43475 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.43438 |
[BP] GO:1900543 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PPARA |
4.4236 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, DRD2, DRD4, FLT3, GRM1, HMGCR, KDR, PIK3CB, PTPN1, SRC, XDH |
4.3957 |
[BP] GO:0045980 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PPARA |
4.3952 |
[BP] GO:0032225 |
None
|
DRD2, DRD3, DRD4, PTGS2 |
4.31362 |
[BP] GO:0007187 |
None
|
ADORA1, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
4.3074 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD2, DRD3, DRD4, SLC6A3 |
4.27118 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FDPS, HMGCR |
4.27112 |
[BP] GO:0060078 |
None
|
ADORA1, DRD4, GRIA2, GRIA4, GRIK5, GRM5 |
4.25136 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3, TYR |
4.22156 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD2, DRD3, DRD4, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, PTGS2, SLC6A3, SRC, TYR |
4.20595 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
4.13118 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
4.13118 |
[BP] GO:0030818 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
4.08951 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CYP19A1, CYP1A1, FDPS, HMGCR, HSD17B2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
4.08951 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, CDC25B, CYP1B1, DRD2, DRD3, ESR1, FABP3, FLT3, HMGCR, IGF1R, KDR, MMP2, MMP9, PIM1, PTGS1, PTGS2, SRC, XDH |
4.04703 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, PIK3CA, PIK3CB, PTPN1, SRC |
4.03948 |
[BP] GO:0030803 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
4.00603 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ALOX15, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.9325 |
[BP] GO:0030815 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.92283 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, DRD3, DRD4, ESR1, ESR2, FABP3, FABP4, FDPS, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SRC, TYR, XDH |
3.92283 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, MET, PIK3CA, PIK3CB, SRC, XDH |
3.90545 |
[BP] GO:1900372 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.89295 |
[BP] GO:0030809 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.89295 |
[BP] GO:0007268 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.88032 |
[BP] GO:0098916 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.88032 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD2, DRD3, DRD4, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, PTGS2, SLC6A3, SRC, TYR |
3.87357 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, HMGCR, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SRC |
3.86614 |
[BP] GO:0030800 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.86428 |
[BP] GO:0099536 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.81054 |
[BP] GO:0099537 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.81054 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, DRD2, DRD4, FLT3, GRM1, HMGCR, IGF1R, KDR, PIK3CB, PTPN1, SRC, XDH |
3.76491 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, DRD4, PPARA, RORC |
3.73103 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
3.73103 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, PIK3CA, PIK3CB, PTPN1, SRC |
3.73103 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD2, DRD3, HCAR2, PIK3CB, PTGS2 |
3.73103 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PIM1, PPARA, PTGS1, PTGS2, TYR |
3.67494 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, MMP2, MMP9, PIK3CA, PTGS2, PTPN1, RORC, SRC |
3.67116 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ALOX15, AXL, CA2, CA7, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, GRIK5, GRM5, HCAR2, HMGCR, IGF1R, KDR, MET, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SRC |
3.66791 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, HCAR2, HMGCR, HSD17B2 |
3.66284 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX15, CYP19A1, FDPS, HMGCR, SLC6A3, TYR |
3.63512 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, HMGCR, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC |
3.63033 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, PIK3CA, PIK3CB, PTPN1, SRC |
3.63019 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9, PTGS2, SLC6A3 |
3.61928 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DRD2, DRD3, ESR1, HMGCR, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
3.6113 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CYP1B1, ESR1, GRIK5, GRM5, IGF1R, MMP2, MMP9, PIK3CA, PTGS2, RORC, SRC |
3.57317 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, AURKB, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, PIK3CA, PIK3CB, PTPN1, SRC |
3.57317 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FDPS |
3.54583 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2 |
3.52492 |
[BP] GO:0051940 |
None
|
DRD2, DRD3, DRD4 |
3.51108 |
[BP] GO:0051584 |
None
|
DRD2, DRD3, DRD4 |
3.51108 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, CA1, DRD2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
3.45969 |
[BP] GO:0042417 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
3.45368 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DRD4, FLT3, GRM1, HMGCR, IGF1R, PIK3CB, PTPN1, SRC |
3.42724 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX15, AXL, CYP1B1, DRD2, DRD3, DRD4, FABP4, FLT3, GRM1, HMGCR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.42424 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, PIK3CA, PIK3CB, PTPN1, SRC |
3.40478 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, DRD2, DRD3, DRD4, SLC6A3 |
3.3526 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ALOX15, AXL, CA2, CA7, CYP19A1, DRD2, DRD3, DRD4, GRIK5, GRM5, HCAR2, HMGCR, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SRC |
3.32478 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
3.32309 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2 |
3.31318 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ALOX15, CDC25B, DRD2, DRD4, ESR1, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.31084 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, DRD2, DRD4, PTGS2 |
3.28144 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, PIK3CA, PIK3CB, PTPN1, SRC |
3.27889 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PIM1, PPARA, PTGS1, PTGS2, TYR |
3.2541 |
[BP] GO:0007194 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.24865 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.24865 |
[BP] GO:0007195 |
None
|
DRD2, DRD3, DRD4 |
3.23492 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.23492 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.23492 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
3.19461 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PIM1, PPARA, PTGS1, PTGS2, TYR |
3.18225 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, AURKB, CDC25B, CYP1B1, CYP2D6, DRD2, DRD3, DRD4, ESR1, ESR2, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, IGF1R, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, XDH |
3.17997 |
[BP] GO:0031280 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.1593 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ALOX15, AURKB, CDC25B, DRD2, DRD3, DRD4, ESR1, ESR2, FABP3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SRC, XDH |
3.1593 |
[BP] GO:0045936 |
None
|
DRD2, DRD3, DRD4, FABP4, GRM3, GRM8, HMGCR, IGF1R, PPARA, PTPN1, XDH |
3.13327 |
[BP] GO:0010563 |
None
|
DRD2, DRD3, DRD4, FABP4, GRM3, GRM8, HMGCR, IGF1R, PPARA, PTPN1, XDH |
3.12859 |
[BP] GO:0034776 |
None
|
DRD2, DRD3, DRD4 |
3.12515 |
[BP] GO:0048511 |
rhythmic process
|
AXL, DRD2, DRD3, DRD4, ESR1, PPARA, RORC, SRC |
3.12312 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, CA2, CA9, CYP1A2, ESR1, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, PTGS2, SRC |
3.11776 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTGS2 |
3.1103 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, AURKB, CDC25B, DRD2, DRD3, DRD4, ESR1, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, IGF1R, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.10526 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ALOX15, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.0926 |
[BP] GO:0051350 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.08659 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, HMGCR, IGF1R, KDR, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC |
3.08402 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, DRD2, DRD3, KDR, SRC |
3.04775 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
3.04775 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX15, ALOX5, PTGS1, PTGS2 |
3.04775 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, AURKB, AXL, CDC25B, DRD2, FDPS, FLT3, HMGCR, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, XDH |
3.04775 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, CDC25B, DRD2, DRD4, ESR1, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.04755 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, CA2, CYP1A1, DRD2, DRD3, GRM1, HMGCR, MMP2, PPARA, PTGS2, SRC, TYR |
3.04392 |
[BP] GO:0007154 |
None
|
ADORA1, AXL, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, PTGS2, SLC1A1, SLC6A2 |
3.02729 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, DRD2, DRD3, DRD4, MMP9, PTGS2 |
2.97928 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ALOX15, AURKB, CDC25B, DRD2, DRD3, DRD4, ESR1, ESR2, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SRC, XDH |
2.97247 |
[BP] GO:0007267 |
None
|
ADORA1, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
2.95225 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CDC25B, DRD2, DRD3, ESR1, FLT3, HMGCR, IGF1R, KDR, MMP2, MMP9, PIM1, PTGS2 |
2.95086 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX15, CYP19A1, DRD2, DRD3, ESR1, ESR2, HMGCR, IGF1R, MET, MMP9, PPARA, PTGS2, PTPN1, SLC6A3, SRC, XDH |
2.94631 |
[BP] GO:0060134 |
None
|
DRD2, DRD3, SLC6A3 |
2.93466 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, MMP1, MMP2, MMP9, PIK3CB, SLC6A3, SRC, XDH |
2.91768 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.87907 |
[BP] GO:0008217 |
None
|
ADORA1, DRD2, DRD3, PPARA, PTGS1, PTGS2 |
2.86436 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, DRD2, DRD4, GRM1, PIK3CA, PIK3CB, PTPN1, SRC |
2.86392 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, PPARA |
2.86345 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.8505 |
[BP] GO:0051580 |
None
|
DRD2, DRD3, DRD4 |
2.8505 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRIK5, GRM1, GRM5, PIK3CA, PIK3CB |
2.81084 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD2, DRD3, ESR1, FABP4, HMGCR, KDR, MET, PPARA, PTGS2, SLC6A3 |
2.80198 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, AURKB, AXL, CDC25B, DRD2, FDPS, FLT3, HMGCR, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, XDH |
2.80114 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, CA2, CA9, CYP1A2, ESR1, FABP3, FLT3, PPARA, PTGS2, SRC |
2.77968 |
[BP] GO:0045761 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.75778 |
[BP] GO:0050801 |
ion homeostasis
|
CA12, CA2, CA7, DRD2, DRD3, DRD4, ESR1, FABP3, GRM1, GRM5, PIK3CB |
2.72483 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
2.69686 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX15, ALOX5, CYP19A1, CYP1A1, FDPS, HMGCR, PTGS1, PTGS2 |
2.68825 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.68788 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX15, ALOX5, PTGS2 |
2.68788 |
[BP] GO:0030817 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.65404 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AURKB, AXL, CA2, CA9, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, FABP4, FLT3, HMGCR, HSD17B2, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RORC, SLC6A3, SRC, TYR |
2.61489 |
[BP] GO:0001504 |
None
|
SLC1A1, SLC6A2, SLC6A3 |
2.61361 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ALOX15, AURKB, CDC25B, DRD2, DRD3, DRD4, ESR1, ESR2, FABP3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SRC, XDH |
2.60146 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, AXL, CA1, CA2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTPN1, RORC, SRC |
2.58039 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, AURKB, CDC25B, DRD2, DRD3, DRD4, ESR1, ESR2, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SRC, XDH |
2.57921 |
[BP] GO:0023052 |
None
|
ADORA1, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
2.57892 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, CYP1A1, CYP1B1, ESR1, FLT3, PTGS2, RORC, SRC |
2.56308 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.56121 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, CA2, DRD2, DRD3, DRD4, ESR1, GRM1, GRM3, GRM5, GRM8, HCAR2, PIK3CA, PIK3CB, SRC |
2.53348 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SRC |
2.52493 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, PIM1, PPARA, RORC, SRC |
2.52423 |
[BP] GO:0015909 |
None
|
DRD2, DRD3, DRD4, FABP3 |
2.51909 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.51909 |
[BP] GO:0051944 |
None
|
DRD2, DRD4 |
2.51909 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.51909 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.51909 |
[BP] GO:0051586 |
None
|
DRD2, DRD4 |
2.51909 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, AURKB, AXL, CYP19A1, CYP1B1, CYP2D6, DRD2, DRD3, DRD4, ESR1, ESR2, FABP3, FABP4, GRM3, GRM8, HCAR2, HMGCR, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A3, SRC, XDH |
2.50118 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.49995 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, DRD4, FLT3, GRM1, PIK3CB, PTPN1, SRC |
2.49995 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.49995 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, CYP1A1, DRD2, PPARA |
2.499 |
[BP] GO:0007626 |
None
|
DRD2, DRD3, DRD4, GRM1, GRM5, SLC6A3 |
2.499 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC |
2.47836 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SRC |
2.47836 |
[BP] GO:0071702 |
None
|
ADORA1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, DRD4, FABP3, PPARA, SLC1A1, SLC6A2, SLC6A3 |
2.46743 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.45117 |
[BP] GO:0048148 |
None
|
DRD2, DRD3, DRD4 |
2.45049 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.45049 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, AURKB, CYP2D6, DRD2, DRD3, DRD4, ESR1, ESR2, FABP4, GRM3, GRM8, HCAR2, HMGCR, IGF1R, KDR, MET, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, RORC, SRC, XDH |
2.44182 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.42168 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2A6, CYP2D6, SLC6A3 |
2.40786 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.39233 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.39233 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.38912 |
[BP] GO:0030814 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.37909 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD2, DRD3, HMGCR, PPARA, SLC6A3 |
2.37804 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CYP19A1, CYP1A1, CYP1A2, ESR1, FLT3, HSD17B2, KDR, PIK3CA, PPARA, SRC, TYR |
2.37419 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AXL, CA2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, FLT3, HSD17B2, KDR, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RORC, SLC6A3, SRC, TYR |
2.37419 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD2, DRD3, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
2.35634 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD2, MET, PIK3CA |
2.35292 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.34473 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, AURKB, CA9, CDC25B, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, DRD3, DRD4, ESR1, ESR2, FABP3, FABP4, FDPS, FLT3, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A3, SRC, XDH |
2.34049 |
[BP] GO:0030802 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.33986 |
[BP] GO:0031279 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.33679 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DRD4, FLT3, GRM1, HMGCR, IGF1R, PIK3CB, PTPN1, SRC |
2.32793 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, FLT3, IGF1R, KDR, PIM1, SRC |
2.32365 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX15, AURKB, AXL, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, FABP4, FLT3, GRM1, HMGCR, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SLC6A3, SRC, XDH |
2.32154 |
[BP] GO:0051339 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.31763 |
[BP] GO:0006810 |
None
|
ACHE, ADORA1, ALOX15, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, DRD4, FABP3, GRIA2, GRIA4, GRIK5, MMP9, PPARA, SLC1A1, SLC6A2, SLC6A3, SRC, XDH |
2.31423 |
[BP] GO:1903963 |
None
|
DRD2, DRD3, DRD4 |
2.30526 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.30526 |
[BP] GO:0050482 |
None
|
DRD2, DRD3, DRD4 |
2.30526 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.30526 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SRC |
2.29986 |
[BP] GO:0033031 |
positive regulation of neutrophil apoptotic process
|
HCAR2, PIK3CB |
2.29986 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.29986 |
[BP] GO:0051582 |
None
|
DRD2, DRD4 |
2.29986 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.29986 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PTGS2, SRC |
2.29986 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
2.28482 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD2, PTGS2 |
2.28433 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AURKB, AXL, CYP19A1, CYP1B1, CYP2D6, DRD2, DRD3, DRD4, ESR1, ESR2, FABP3, FABP4, GRM3, GRM8, HMGCR, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, XDH |
2.2766 |
[BP] GO:0098657 |
import into cell
|
ACHE, ADORA1, ALOX15, AXL, DRD2, DRD3, SLC1A1, SLC6A2, SLC6A3 |
2.27476 |
[BP] GO:0042391 |
None
|
ADORA1, DRD4, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
2.27476 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.27476 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
CA12, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5, PIK3CB |
2.27428 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B2 |
2.27428 |
[BP] GO:0008299 |
None
|
CYP1A1, FDPS, HMGCR |
2.27428 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.27428 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, FDPS, HMGCR, HSD17B2 |
2.26634 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, DRD2, FABP3, FABP4, MET, PIK3CA, PIK3CB |
2.25431 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, AURKB, AXL, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, FLT3, GRM1, HMGCR, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.24521 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, AURKB, CDC25B, DRD2, DRD4, ESR1, ESR2, FLT3, GRM1, GRM5, MET, MMP9, PIK3CA, PIK3CB, PTPN1, SRC, XDH |
2.24521 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTGS2 |
2.2405 |
[BP] GO:0019725 |
cellular homeostasis
|
CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRIK5, GRM1, GRM5, PIK3CA, PIK3CB |
2.23804 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
DRD2, DRD3, PIK3CA, SLC6A3 |
2.22885 |
[BP] GO:1900371 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.22839 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CYP1A1, ESR1, FLT3, MET, PIK3CB, PIM1, SRC, TYR |
2.22472 |
[BP] GO:0051179 |
None
|
ACHE, ADORA1, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, DRD4, ESR1, FABP3, GRIA2, GRIA4, GRIK5, MMP9, PPARA, SLC1A1, SLC6A2, SLC6A3, SRC, XDH |
2.21766 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, PPARA, RORC, SRC |
2.21766 |
[BP] GO:0030808 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.21766 |
[BP] GO:0051234 |
None
|
ACHE, ADORA1, ALOX15, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, DRD4, FABP3, GRIA2, GRIA4, GRIK5, MMP9, PPARA, SLC1A1, SLC6A2, SLC6A3, SRC, XDH |
2.21441 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.21263 |
[BP] GO:0015718 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
2.1959 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HMGCR |
2.1959 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.1959 |
[BP] GO:0035235 |
None
|
GRIA2, GRIA4, GRIK5 |
2.1959 |
[BP] GO:0032309 |
None
|
DRD2, DRD3, DRD4 |
2.1959 |
[BP] GO:0001975 |
None
|
DRD2, DRD3, DRD4 |
2.1959 |
[BP] GO:0007610 |
None
|
DRD2, DRD3, DRD4, GRM1, GRM5, HMGCR, PPARA, PTGS2, SLC6A3 |
2.16257 |
[BP] GO:0007612 |
None
|
DRD2, DRD3, GRM5, HMGCR, PTGS2 |
2.14148 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, CA2, DRD2, DRD3, DRD4, HCAR2, HMGCR, PTGS2, PTPN1, SRC |
2.13838 |
[BP] GO:0030100 |
regulation of endocytosis
|
ALOX15, AXL, DRD2, PIK3CB, PTPN1, SRC |
2.13334 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.13334 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.13334 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, DRD2, DRD3, ESR1, ESR2, HMGCR, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
2.10519 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, DRD4, GRIK5, HCAR2, HMGCR, SRC |
2.10519 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD4, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SLC6A2, SRC |
2.10044 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
2.09914 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, DRD2, DRD3, ESR1, ESR2, HMGCR, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
2.09631 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PTGS2, SRC |
2.09328 |
[BP] GO:0006954 |
inflammatory response
|
ADORA1, ADORA3, ALOX15, AXL, PIK3CA, PIK3CB, PTGS1, PTGS2 |
2.08135 |
[BP] GO:0031214 |
biomineral tissue development
|
ALOX15, ALPL, PPARA, PTGS2 |
2.08135 |
[BP] GO:0032413 |
None
|
DRD2, DRD3, DRD4, MMP9 |
2.08135 |
[BP] GO:0071715 |
None
|
DRD2, DRD3, DRD4 |
2.08135 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX15, PTGS1, PTGS2 |
2.08135 |
[BP] GO:0033280 |
response to vitamin D
|
ALPL, PTGS2, TYR |
2.08135 |
[BP] GO:1901571 |
None
|
DRD2, DRD3, DRD4 |
2.08135 |
[BP] GO:0030799 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.0796 |
[BP] GO:0051952 |
None
|
ADORA1, DRD2, DRD3, DRD4 |
2.06546 |
[BP] GO:0046717 |
None
|
DRD2, DRD3, DRD4, SLC1A1 |
2.04459 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, HMGCR |
2.0413 |
[BP] GO:0030003 |
cellular cation homeostasis
|
CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5, PIK3CB |
2.03751 |
[BP] GO:1900542 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PPARA |
2.00614 |
[BP] GO:0042220 |
None
|
DRD2, DRD3, SLC6A3 |
2.00614 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
IGF1R, PIK3CA, PIK3CB |
2.00614 |
[BP] GO:0045744 |
None
|
DRD2, DRD3, MET |
2.00614 |
[BP] GO:0010039 |
response to iron ion
|
CYP1A1, DRD2, SLC6A3 |
2.00614 |
[BP] GO:0033029 |
regulation of neutrophil apoptotic process
|
HCAR2, PIK3CB |
2.00381 |
[BP] GO:0032415 |
None
|
DRD3, DRD4 |
2.00381 |
[BP] GO:0051934 |
None
|
SLC6A2, SLC6A3 |
2.00381 |
[BP] GO:0021984 |
None
|
DRD2, SLC6A3 |
2.00381 |
[BP] GO:0090494 |
None
|
SLC6A2, SLC6A3 |
2.00381 |
[BP] GO:0090493 |
None
|
SLC6A2, SLC6A3 |
2.00381 |
[BP] GO:0051583 |
None
|
SLC6A2, SLC6A3 |
2.00381 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX15, ALOX5 |
2.00381 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2D6 |
2.00381 |
[BP] GO:1901570 |
None
|
ALOX15, ALOX5, PTGS1, PTGS2 |
2.00381 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, DRD2, DRD3, DRD4, HCAR2, HMGCR, SRC |
2.0024 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ALOX15, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, DRD3, DRD4, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD17B2, IGF1R, KDR, MET, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, SLC1A1, SLC6A2, SLC6A3, SRC, TYR |
4.9327 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALOX15, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, DRD2, DRD3, DRD4, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTPN1, SLC1A1, SLC6A2, SLC6A3, SRC |
4.69501 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX15, ALOX5, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, DRD3, DRD4, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD17B2, IGF1R, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SLC1A1, SLC6A2, SLC6A3, SRC, TYR |
4.50078 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, PTGS2, SLC1A1, SRC |
4.37431 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, AXL, CA4, DRD2, DRD3, DRD4, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3 |
4.08951 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ALOX15, AXL, CA2, CA4, CA9, DRD2, DRD3, DRD4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PTGS2, SLC1A1, SLC6A2, SLC6A3, SRC |
4.05924 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, DRD2, DRD4, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A3, SRC |
3.89295 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, AXL, DRD2, DRD3, DRD4, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3 |
3.75125 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.46802 |
[CC] GO:0043005 |
None
|
ADORA1, CA2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PTGS2, SLC6A2, SLC6A3, SRC |
3.36337 |
[CC] GO:0014069 |
None
|
ADORA1, DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
3.1593 |
[CC] GO:0099572 |
None
|
ADORA1, DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
3.1593 |
[CC] GO:0098794 |
None
|
ADORA1, DRD2, DRD4, GRIA2, GRIA4, GRM3 |
2.8247 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, CA2, DRD2, DRD3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PIK3CA, PTGS2, SLC6A2, SLC6A3, SRC |
2.75156 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, CA2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PIK3CA, PTGS2, SLC6A2, SLC6A3, SRC |
2.4911 |
[CC] GO:0043197 |
None
|
ADORA1, DRD2, GRIA2, GRIA4, GRM3 |
2.35292 |
[CC] GO:0044309 |
None
|
ADORA1, DRD2, GRIA2, GRIA4, GRM3 |
2.32692 |
[CC] GO:0097060 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.32133 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, GRIA2, HMGCR, HSD17B2, PTGS1, PTGS2 |
2.27428 |
[CC] GO:0097458 |
None
|
ADORA1, CA2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS1, PTGS2, SLC6A2, SLC6A3, SRC |
2.24521 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FLT3, GRIA2, HMGCR, HSD17B2, PTGS1, PTGS2, PTPN1 |
2.08805 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.00381 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
17.0253 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, ESR1, ESR2, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
15.4481 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, DRD3, DRD4, ESR1, ESR2, FABP3, FABP4, FDPS, FLT3, HMGCR, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SRC, TYR, XDH |
11.3772 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.8187 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
9.6099 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, DRD3, DRD4, ESR1, ESR2, FDPS, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, TYR, XDH |
9.4241 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
8.45754 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.35068 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2, SRC |
7.64326 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HMGCR, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
7.43846 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2, SRC |
7.40229 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FDPS, FLT3, HMGCR, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SRC, TYR, XDH |
7.20111 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, ESR1, ESR2, FDPS, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, TYR, XDH |
7.16263 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
7.01541 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2, TYR |
6.99869 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, XDH |
6.8868 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, MMP1, MMP2, MMP9, NQO2, PPARA, PTPN1, RORC |
6.85475 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD2, DRD3, DRD4, ESR1, ESR2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, RORC |
6.39004 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
6.3769 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
6.17551 |
[MF] GO:0030594 |
None
|
DRD2, DRD3, DRD4, GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
5.76437 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, DRD2, DRD3, DRD4, ESR1, ESR2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, RORC |
5.56455 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, DRD2, DRD3, DRD4, FLT3, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, SLC6A3, SRC |
5.46112 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
5.43596 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HMGCR, NQO2, PTGS1, PTGS2, SRC, XDH |
5.43133 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, DRD2, DRD3, DRD4, ESR1, ESR2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, RORC |
5.35289 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, DRD2, DRD3, DRD4, ESR1, ESR2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, RORC |
4.9327 |
[MF] GO:0035240 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
4.63909 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
4.56173 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, DRD2, DRD3, DRD4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET |
4.37431 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD2, DRD3, DRD4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET |
4.37431 |
[MF] GO:1901338 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
3.95148 |
[MF] GO:0001591 |
None
|
DRD2, DRD3, DRD4 |
3.51108 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.46802 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD2, DRD3, DRD4, SLC6A3 |
3.17196 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, PIK3CA, PIK3CB |
3.12515 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.04755 |
[MF] GO:0004952 |
None
|
DRD2, DRD3, DRD4 |
3.03333 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.91966 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.91966 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.91966 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, PPARA, RORC |
2.62586 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, PPARA, RORC |
2.62586 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.51909 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A3 |
2.51909 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.51909 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.49995 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.49995 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.49995 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.47836 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, PPARA, RORC |
2.37909 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.29986 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.29986 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX15, ALOX5, PTGS2 |
2.1959 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX15, ALOX5, PTGS2 |
2.14832 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, HMGCR, HSD17B2, XDH |
2.14148 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.13334 |
[MF] GO:0051721 |
None
|
HMGCR, PTPN1, SLC6A3 |
2.10996 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, DRD2, DRD4, ESR1, ESR2, FLT3, GRIK5, HMGCR, IGF1R, KDR, MET, MMP9, NQO2, PTGS2, TYR, XDH |
2.10052 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.00614 |
[MF] GO:0005329 |
None
|
SLC6A2, SLC6A3 |
2.00381 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.00381 |